Yes, you can give prednisone 60 mg daily for one week without a taper in most adult patients.
For short-term courses of prednisone (≤2 weeks), tapering is unnecessary and not supported by evidence. The FDA label explicitly states that abrupt withdrawal should be avoided after "long-term therapy," not short courses 1. The critical threshold for HPA axis suppression requiring a taper is approximately 3 weeks of therapy at doses >7.5 mg daily 2.
Key Evidence Supporting No Taper for One Week
The FDA labeling confirms that prednisone 60 mg daily falls within the acceptable initial dosing range (5-60 mg/day depending on condition) and specifically notes that gradual withdrawal is recommended only "if after long-term therapy the drug is to be stopped" 1. One week does not constitute long-term therapy.
Research directly supports this approach:
- An 8-day course of prednisone 40 mg daily without taper showed no difference in adrenal suppression or relapse rates compared to a tapered regimen in asthma patients 3
- Multiple studies confirm that HPA axis suppression requiring intervention occurs after >3 weeks of therapy, not after 1 week 2, 4
Clinical Reasoning
The physiologic basis: HPA axis suppression becomes clinically significant only with prolonged exposure (>3 weeks). A one-week course at 60 mg daily will suppress the axis temporarily, but recovery occurs rapidly after discontinuation without need for tapering 2.
Practical considerations:
- Administer in the morning (before 9 AM) to minimize HPA suppression 1
- Take with food to reduce gastric irritation 1
- Consider antacids if using high doses 1
Important Caveats
Do NOT stop abruptly without taper if:
- Patient has been on chronic steroids (>3 weeks at >7.5 mg/day) 2
- Patient is already on maintenance corticosteroids
- Patient has known adrenal insufficiency
Monitor for complications during the one-week course:
- Screen for pre-existing comorbidities (diabetes, hypertension, peptic ulcer disease, infections) before initiating 2
- Patients with these conditions require closer monitoring but can still receive short courses
Common pitfall: Many clinicians unnecessarily taper short courses due to outdated teaching. The evidence shows this adds no benefit and may prolong exposure to corticosteroids 3, 5. The guideline concern about tapering applies to chronic medium/high-dose therapy (>3 weeks), not acute one-week courses 2.